The toxicity profile of non-selective FGFR inhibitors is similar to that of VEGFR TKIs, which include fatigue, anorexia, pyrexia, diarrhea, arthralgia, liver toxicity, hypertension, proteinuria, thrombotic microangiopathy, and hypothyroidism. The gene discussed is KDR; the disease is Genetic thrombotic microangiopathy.